IceCure Medical Growth Metrics (2021-2026) | ICCM

Growth Metrics Dec2021 Dec2022 Dec2023 Dec2024 Mar2025 Dec2025 Mar2026
Growth Ratios
Assets Growth (1y) (Quarter) 215.27%-6.48%-45.64%-23.36%10.43%
Assets Growth (3y) (Quarter) 17.03%-26.96%-22.80%
Assets Growth (5y) (Quarter) 6.29%
Assets (QoQ) (Quarter) -4.21%
Capital Expenditures Growth (1y) (Quarter) -750.00%
Cash & Equivalents Growth (1y) (Quarter) 631.61%-7.66%-55.48%-28.19%17.62%34.35%
Cash & Equivalents Growth (3y) (Quarter) 44.35%-33.41%-27.82%
Cash & Equivalents Growth (5y) (Quarter) 20.50%
Cash & Equivalents (QoQ) (Quarter) -20.15%-8.79%
Cash from Investing Activities Growth (1y) (Quarter) -750.00%
Cash from Operations Growth (1y) (Quarter) -5.77%
EBITDA Margin Growth (1y) (Quarter) -3822.00
EBIT Growth (1y) (Quarter) 16.13%
EBIT Margin Growth (1y) (Quarter) -3822.00
EBT Growth (1y) (Quarter) 16.13%
EBT Margin Growth (1y) (Quarter) -3822.00
Enterprise Value Growth (1y) (Quarter) -213.56%6.50%53.82%31.62%-17.62%-34.35%
Enterprise Value Growth (3y) (Quarter) -10.62%33.41%28.12%
Enterprise Value Growth (5y) (Quarter) -1.72%
Enterprise Value (QoQ) (Quarter) 20.15%8.79%
EPS (Basic) Growth (1y) (Quarter) 16.13%
EPS (Weighted Average and Diluted) Growth (1y) (Quarter) -9.02%
FCF Margin Growth (1y) (Quarter) 9,291.00
Free Cash Flow Growth (1y) (Quarter) -4.66%
Gross Margin Growth (1y) (Quarter) 231.00
Gross Profit Growth (1y) (Quarter) 35.32%
Net Cash Flow Growth (1y) (Quarter) 47.03%
Net Income Growth (1y) (Quarter) 16.13%
Net Income towards Common Stockholders Growth (1y) (Quarter) 16.13%
Net Margin Growth (1y) (Quarter) -3822.00
Operating Income Growth (1y) (Quarter) 16.13%
Operating Margin Growth (1y) (Quarter) -3822.00
Profit After Tax Growth (1y) (Quarter) -219.12%
Property, Plant & Equipment (Net) Growth (1y) (Quarter) 132.25%90.18%11.58%-17.25%-20.69%
Property, Plant & Equipment (Net) Growth (3y) (Quarter) 70.18%20.64%-9.86%
Property, Plant & Equipment (Net) Growth (5y) (Quarter) 26.46%
Property, Plant & Equipment (Net) (QoQ) (Quarter) -1.81%
Return on Sales Growth (1y) (Quarter) 0.00
Revenue Growth (1y) (Quarter) 25.66%
Share-based Compensation Growth (1y) (Quarter) 44.00%
Shareholder's Equity Growth (1y) (Quarter) 377.30%-5.70%-52.16%-43.26%31.15%
Shareholder's Equity Growth (3y) (Quarter) 29.14%-36.50%-29.12%
Shareholder's Equity Growth (5y) (Quarter) 9.89%
Total Debt Growth (1y) (Quarter) -18.58%-91.93%
Total Debt Growth (3y) (Quarter) -36.13%
Total Debt Growth (5y) (Quarter) -55.67%